Actilyse®

Thrombolytic treatment in acute myocardial infarction. Thrombolytic treatment in acute massive pulmonary embolism with haemodynamic instability. Thrombolytic treatment of acute ischaemic stroke.

Fibrinolytic treatment of acute ischaemic stroke, acute myocardial infarction, acute massive pulmonary embolism. Fibrinolytic treatment of occluded catheters.

Indications

Thrombolytic treatment in acute myocardial infarction.

Thrombolytic treatment in acute massive pulmonary embolism with haemodynamic instability.

Thrombolytic treatment of acute ischaemic stroke.
Brand Names Actilyse®
Active ingredients alteplase
Packshot Praxbind<sup><sup>®</sup></sup>

References:

  1. Walter Johnson, Oyere Onuma, Mayowa Owolabic & Sonal Sachdeva. Stroke: a global response is needed. Bull World Health Organ 2016;94:634–634A.
  2. Calvin Ke et al. Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study. Lancet Glob Health 2018;6: e914–23
  3. Padma MV. “Telestroke”: An Indian approach to telemedicine. J Pract Cardiovasc Sci 2017;3:2-4.
  4. ACTILYSE ® India pack insert version dated 5 May 2017